Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical…
Read More »
MD Anderson and Myriad Genetics form strategic alliance to evaluate…
Trial underscores IROS’s commitment to developing innovative therapies for unmet…
SALT LAKE CITY, January 3, 2025—ARUP Laboratories today launched a…
Sethera Therapeutics Completes First Funding Round
Data from Dual-Acting Oral Biologic Show Promising Safety and Efficacy…
Recent in-vitro lab results confirm that the Company’s Smart mRNA…
Unique cell-impermeable1 design extends life-saving treatment for dialysis patients.
A new report from the U.’s Kem C. Gardner Policy…
Teva to provide two generic inhaler products to Direct Relief…
Study Demonstrates RiskScore as a More Accurate Predictor of Breast…
Human Forms and Body Parts Trigger Strong Reactions in the…
Partnership aims to set new industry standards for managing mental…
SINTX TECHNOLOGIES SECURES PATENT ALLOWANCE FOR WIDE-RANGING SILICON NITRIDE BIOMATERIAL…
BD has reached an agreement with the U.S. SEC to…
VALENCIA, Calif. – Dec. 3, 2024 – Nusano, a physics…
SALT LAKE CITY, Dec. 10, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the…
LEHI, Utah, Dec. 10, 2024 /PRNewswire/ — Halia Therapeutics, a…
Recursion reported initial monotherapy dose-escalation data from the Phase 1/2…
With limited options available to treat Pancreatic Ductal Adenocarcinoma (PDAC),…
Notifications
